EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Epidemiology of thyroid-stimulating immunoglobulin in recent-onset symptomatic thyroid eye disease

Kenneth Ka Hei Lai, Fatema Mohamed Ali Abdulla Aljufairi, Jake Uy Sebastian, Yingying Wei, Ruofan Jia, Karen Kar Wun Chan, Elaine Yuen Ling Au, Alan Chun Hong Lee, Chiu Ming Ng, Hunter Kwok Lai Yuen, Wilson Wai Kuen Yip, Alvin Lerrmann Young und 4 weitere

European Thyroid Journal · 2024

DOI: 10.1530/etj-23-0129 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Thyroid Journal, 2024. Verfasst von Kenneth Ka Hei Lai und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology and Visual Sciences, Prince of Wales Hospital, Hong Kong Special Administrative Region, China. Hauptthemen laut MEDLINE: Graves Ophthalmopathy, Immunoglobulins, Thyroid-Stimulating. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

This study aims to report correlations between thyroid-stimulating immunoglobulin (TSI) and both clinical and radiological parameters in recent-onset symptomatic thyroid eye disease (TED) patients.

Methods

A prospective cohort study of TED patients managed at the Chinese University of Hong Kong from January 2014 to May 2022. Serum TSI levels were determined with the functional assay. Outcomes included the Clinical Activity Score (CAS), marginal reflex distance1 (MRD1), extraocular muscle motility restriction (EOMy), exophthalmos, and diplopia. The radiological assessment included cross-sectional areas and signal of extraocular muscles on STIR-sequence MRI.

Results

A total of 255 (197 female) treatment-naive patients, with an average onset age of 50 ± 14 years (mean ± s.d. ), were included. Elevated pre-treatment TSI level was observed in 223 (88%) patients. There was a weak positive correlation between TSI and CAS ( r = 0.28, P = 0.000031), MRD1 ( r = 0.17, P = 0.0080), and the size of the levator palpebrae superioris/superior rectus complex ( r = 0.25, P = 0.018). No significant correlation existed between TSI and STIR signals. The AUC and optimal cut-off value for clinical active TED were 0.67 (95% CI: 0.60–0.75) and 284% (specificity: 50%, sensitivity: 85%). In total, 64 patients received intravenous methylprednisolone (IVMP) during the study interval, and they had a higher baseline TSI level than those who did not have IVMP ( P = 0.000044). Serial post-IVMP TSI among the 62 patients showed a significant reduction compared to the baseline level ( P < 0.001). Both the baseline and post-IVMP TSI levels, and percentages of TSI changes were comparable between patients who responded and did not respond to the first course of IVMP.

Conclusion

TSI can be a serum biomarker for the diagnosis, prognosis, and treatment response of TED. Further validation should be warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Graves OphthalmopathyImmunoglobulins, Thyroid-StimulatingHumansFemaleMaleMiddle AgedProspective StudiesAdultAgedOculomotor MusclesHong KongMagnetic Resonance ImagingDiplopiaExophthalmos

Stichwörter der Autor:innen

thyroid eye diseasethyroid-stimulating immunoglobulin

Substanzen

Immunoglobulins, Thyroid-Stimulating

Autor:innen und Institutionen

  • Department of Ophthalmology and Visual Sciences, Prince of Wales Hospital, Hong Kong Special Administrative Region, China.
  • Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China.
  • Department of Ophthalmology, Salmaniya Medical Complex, Government Hospitals, Bahrain.
  • Department of Ophthalmology, Vicente Sotto Memorial Medical Center, Cebu City, Philippines.
  • Department of Statistics, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China.
  • Division of Clinical Immunology, Department of Pathology, Queen Mary Hospital, Hong Kong Special Administrative Region, China.

ORCID-Profile: Kelvin Kam Lung Chong

Zitieren

APA

Lai, K. K. H., Aljufairi, F. M. A. A., Sebastian, J. U., Wei, Y., Jia, R., Chan, K. K. W., Au, E. Y. L., Lee, A. C. H., Ng, C. M., Yuen, H. K. L., Yip, W. W. K., Young, A. L., Cheng, G. P. M., Tham, C. C. Y., Pang, C. P., & Chong, K. K. L. (2024). Epidemiology of thyroid-stimulating immunoglobulin in recent-onset symptomatic thyroid eye disease. European Thyroid Journal. https://doi.org/10.1530/etj-23-0129

Vancouver

Lai KKH, Aljufairi FMAA, Sebastian JU, Wei Y, Jia R, Chan KKW, et al. Epidemiology of thyroid-stimulating immunoglobulin in recent-onset symptomatic thyroid eye disease. European Thyroid Journal. 2024. doi:10.1530/etj-23-0129

BibTeX
@article{Lai2024,
  author = {Lai, Kenneth Ka Hei and Aljufairi, Fatema Mohamed Ali Abdulla and Sebastian, Jake Uy and Wei, Yingying and Jia, Ruofan and Chan, Karen Kar Wun and Au, Elaine Yuen Ling and Lee, Alan Chun Hong and Ng, Chiu Ming and Yuen, Hunter Kwok Lai and Yip, Wilson Wai Kuen and Young, Alvin Lerrmann and Cheng, George Pak Man and Tham, Clement Chee Yung and Pang, Chi Pui and Chong, Kelvin Kam Lung},
  title = {Epidemiology of thyroid-stimulating immunoglobulin in recent-onset symptomatic thyroid eye disease},
  journal = {European Thyroid Journal},
  year = {2024},
  doi = {10.1530/etj-23-0129}
}
Kostenlos starten →